The Amsterdam Institute for Global Health and Development (aighd) is posting the Global Roadmap for R&D for TB vaccines (roadmap) that they have been developing with key stakeholders ( [...]
SATVI has an vacancy for a Project Manager at their offices in South African, Cape Town. Vacancy details: The South African Tuberculosis Vaccine Initiative (SATVI) performs cutting edge clinical, [...]
The University of Geneva has opened a tenure-track position for an assistant professor of human vaccine immunology… endowed by a Charity prior to a permanent University position as [...]
Prof. Kaufmann, chair of the scientific board of TBVAC2020 and member of the TBVI board, was honored with the Gagna A. & Ch. Van Heck Prize in recognition of his and his team’s work on [...]
Press release: New live attenuated TB vaccine is safe and shows a distinct, dose dependent immune response in a Phase1b trial in newborns
The initial results of the Phase 1b study have been presented at the 5th Global Forum on TB vaccines in Delhi. Please read the press release.
A new TB vaccine is an inevitability; the question is how long will it take us to get there? Please read the article about progress and challenges in TB vaccine development.